$1.34
Value $8.2M
CardlyticsvsMicrosoft
CDLX and MSFT stock compared: price, dividend, valuation and results, from SEC filings.
-6.29%
$523.88
Value $3.89T
Cardlytics (CDLX) has a market value of $8.2M and Microsoft (MSFT) $3.89T. Over the last year, with dividends, CDLX moved -91.1% and MSFT +3.3%. Dividend yield: CDLX none, MSFT 0.69%.
At a glance
The main figures of both. A bar only shows which number is larger, not which is better.
Market value
CDLX$8.2M
MSFT$3.89T
MSFT is 475,804 times CDLX
Revenue, 12 months
CDLX$176M
MSFT$346B
MSFT is 1,969 times CDLX
Net income, 12 months
CDLX-$37M
MSFT$143B
Operating margin
CDLX-19.2%
MSFT47.1%
66.3 points apart
ROIC
CDLX-11.8%
MSFT28.7%
40.4 points apart
P/E
CDLX–
MSFT27.3
Dividend yield
CDLX0.0%
MSFT0.7%
0.7 points apart
5-year return
CDLX-99.9%
MSFT+62.1%
162.0 points apart
A fainter bar means a negative number. The 5-year return includes dividends.
The price over time
Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.
CDLX-99.9%
MSFT+62.1%
| Period | CDLXWith dividends | MSFTWith dividends |
|---|---|---|
| 1 year since November 12, 2025 | -91.1%Price -91.1% | +3.3%Price +2.5% |
| 3 years since November 13, 2023 | -98.2%-73.7% a yearPrice -98.2% | +46.2%+13.5% a yearPrice +42.9% |
| 5 years since November 12, 2021 | -99.9%-72.9% a yearPrice -99.9% | +62.1%+10.1% a yearPrice +55.6% |
Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.
Every figure
As on each company's page. A description, not a recommendation: no one figure says which is better.
CDLXCardlyticsMSFTMicrosoft
Valuation
CDLXMSFT| Price | $1.34 | $523.88 |
|---|---|---|
| Market value | $8.2M | $3.89T |
| Enterprise value (EV) | $173M | $3.93T |
| P/E | – | 27.3 |
| P/E, 5-year median | – | 35.2 |
| P/B | – | 8.3 |
| EV/EBIT | – | 24.1 |
| Free cash flow yield | – | 1.5% |
Results and growth
CDLXMSFT| Revenue, 12 months | $176M | $346B |
|---|---|---|
| Net income, 12 months | -$37M | $143B |
| Free cash flow, 12 months | -$7.2M | $60.0B |
| Earnings per share, 12 months | -$19.50 | $19.16 |
| Revenue growth, year on year | -16.2% | 17.8% |
| Revenue growth a year, past | +4.5%over 5 years | +14.6%over 5 years |
| EPS growth a year, past | – | +17.4%over 5 years |
Margins and returns on capital
CDLXMSFT| Gross margin | – | 67.7% |
|---|---|---|
| Operating margin | -19.2% | 47.1% |
| Net margin | -20.8% | 41.2% |
| ROIC | -11.8% | 28.7% |
| ROE | – | 34.3% |
Balance sheet
CDLXMSFT| Cash | $30M | $64.5B |
|---|---|---|
| Total debt | $200M | $134B |
| Net debt / EBITDA | – | 0.2 |
| Interest cover | – | 50.6× |
Dividends and buybacks
CDLXMSFT| Dividend yield | – | 0.7% |
|---|---|---|
| Dividend per share, 12 months | – | $3.64 |
| Dividend growth a year, past | – | +10.2%over 5 years |
| Buyback yield | – | 0.6% |
| Shareholder yield | – | 1.3% |
Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.
Which is bigger, Cardlytics or Microsoft?
By market value, Microsoft ($3.89T) is about 475,804.4 times Cardlytics ($8.2M), at today's prices.
How did CDLX and MSFT stock do over the last 5 years?
Since November 12, 2021, CDLX's price moved -99.9% and MSFT's +55.6%. With dividends: CDLX -99.9% (-72.9% a year), MSFT +62.1% (+10.1% a year). Past returns do not predict future ones.
Which pays the higher dividend, CDLX or MSFT?
The dividend yield at today's price is none for Cardlytics and 0.69% for Microsoft. Over the last twelve months they paid – and $3.64 per share.
Which has the higher profit margins, Cardlytics or Microsoft?
Over the last twelve months, the net margin was -20.8% for Cardlytics and 41.2% for Microsoft, and the operating margin -19.2% and 47.1%. Revenue was $176M and $346B.
Which is the better investment, Cardlytics or Microsoft?
The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.
Other comparisons
With each of the two, and with the largest in its sector.
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
US stocksThe market today, the sectors, the largest companies and the week's results.The market's sectorsThe 11 sectors side by side: returns, share of the market, median P/E and dividend.Compare stocksTwo companies side by side: price over up to ten years, with and without dividends, and every figure.US dividend stocksEach dividend's yield next to whether the company's cash covers it and whether it was ever cut.
Descriptive data from SEC filings and market prices.